dr. petrylak discusses bcg for the treatment of patients with non-invasive bladder cancer
Published 8 years ago • 1.5K plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
1:08
future treatment approaches for patients with bladder cancer
-
10:46
new treatment of non-muscle-invasive bladder cancer
-
2:01
benign prostatic hyperplasia - mircea cristescu, md
-
50:00
novel therapies to non muscle invasive bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
0:59
dr. galsky on progression on immunotherapy in bladder cancer
-
0:44
role of immunotherapy in bladder cancer
-
27:43
treating non-muscle invasive bladder cancer - bivalacqua - dc
-
1:48
dr. ramos on the role of bcg in non-muscle invasive bladder cancer
-
27:09
detail: chemotherapy & immunotherapy (bcg) for non muscle invasive bladder cancer
-
2:21
novel treatments in muscle invasive and non-muscle invasive bladder cancer
-
26:20
management of non-muscle invasive bladder cancer
-
51:36
treatment of high risk nmibc in era of bcg shortage - empire urology lecture series